elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28543430-31183FCF-938F-4959-AD8E-4D23247C1CA9
Q28543430-31183FCF-938F-4959-AD8E-4D23247C1CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543430-31183FCF-938F-4959-AD8E-4D23247C1CA9
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders
P2860
Q28543430-31183FCF-938F-4959-AD8E-4D23247C1CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543430-31183FCF-938F-4959-AD8E-4D23247C1CA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
faaf5081db2e5f80d5bf2522ab8b7f8346e7fa73
P2860
Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.